The Ozempic Indulgence ShiftWhere are the areas of growth in GLP-1’s big shrink?Tuesday 25 Mar 2025
Summary

Ozempic is rewiring people's relationships with cravings, indulgence, and restraint. For this month's live expert event, we’re reviewing how GLP-1 drugs are changing how and where people choose to indulge — from dialling down food cravings to moderating alcohol consumption. As self-control and desire go head to head, where should brands show up?

Featured Speakers

Amy Bentley is a professor in the Department of Nutrition and Food Studies at New York University. A historian with interests in the social and cultural contexts of food and nutrition, she is the author of several books and articles, including the award-winning Inventing Baby Food: Taste, Health, and the Industrialization of the American Diet. Current projects include the meanings and uses of GLP-1 drugs, a history of food in US hospitals, the cultural and historical contexts of meat and dairy substitutes, the cultural contexts of food waste, and the role of flavour in human and planetary health. She is the co-founder of the NYU Urban Farm Lab.

View expert

Leah Sinclair is a senior commissioning editor at Canvas8 and a freelance journalist whose bylines include Stylist Magazine, The Guardian, Grazia, Evening Standard and more. Her work explores culture, lifestyle and consumer trends, and she has previously worked as a senior digital writer and news reporter across UK media. At Canvas8, she focuses on how cultural shifts, from entertainment and fashion to sport and fandom, are reshaping the way audiences engage with brands and experiences. Her work examines fandom through case studies she has commissioned on brands such as Fanatics UK and Swifftogedden, as well as reports exploring how tracking culture has become key to fan experiences and why they’re also gathering offline to seek connection